Gina Rivero
Family · Picayune, MSNPI 1376713313
Payments from drug & device makers
Across 148 payments — averaging $27.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$1K
- AbbVie$904
- Lilly USA, LLC$302
- Novartis$276
- Corcept Therapeutics$229
- Novo Nordisk$128
- plus $1K from 22 others
What the payments were for
- Travel & lodging$2927%
- Food & beverage$3,84993%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 16 | $1,205 |
| AbbVie | 41 | $904 |
| Lilly USA, LLC | 18 | $302 |
| Novartis | 12 | $276 |
| Corcept Therapeutics | 4 | $229 |
| Novo Nordisk | 7 | $128 |
| Regeneron Healthcare Solutions, Inc. | 1 | $125 |
| Xeris Pharmaceuticals, Inc. | 4 | $97 |
| Neurocrine Biosciences, Inc. | 2 | $88 |
| Phathom Pharmaceuticals, Inc. | 4 | $78 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 4 | $73 |
| Biohaven Pharmaceuticals, Inc. | 4 | $71 |
| Exact Sciences | 4 | $70 |
| Abbott | 4 | $68 |
| Boehringer Ingelheim | 4 | $67 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $57 |
| Merck | 2 | $49 |
| Amarin Pharma, Inc. | 2 | $40 |
| Pfizer | 2 | $34 |
| Amgen | 2 | $25 |
| Agile Therapeutics, Inc. | 1 | $22 |
| Mylan Specialty L.p. | 1 | $22 |
| Bayer | 1 | $22 |
| Teleflex LLC | 1 | $21 |
| Ironwood Pharmaceuticals, Inc | 1 | $18 |
| Dexcom, Inc. | 1 | $17 |
| Astellas Pharma US Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,142 in reported general payments places this provider in the 90th percentile of 3,007 family providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 317 | $279,220 |
| MounjaroTirzepatide | 113 | $134,279 |
| OzempicSemaglutide | 103 | $123,566 |
| EliquisApixaban | 56 | $55,133 |
| TrulicityDulaglutide | 28 | $37,491 |
| FarxigaDapagliflozin Propanediol | 40 | $36,468 |
| MyrbetriqMirabegron | 49 | $34,059 |
| VraylarCariprazine Hcl | 20 | $26,995 |
| LinzessLinaclotide | 28 | $21,568 |
| JanuviaSitagliptin Phosphate | 23 | $21,206 |
| Janumet XrSitagliptin Phos/Metformin Hcl | 15 | $20,315 |
| XareltoRivaroxaban | 13 | $18,093 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 17 | $17,044 |
| NeuproRotigotine | 12 | $9,330 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 43 | $8,670 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $67 | $279,220317 claims |
| Lilly USA, LLCMounjaro, Trulicity | $302 | $171,771141 claims |
| Novo NordiskOzempic | $128 | $123,566103 claims |
| PfizerEliquis | $34 | $55,13356 claims |
| AbbVieVraylar, Linzess, Synthroid | $904 | $50,94681 claims |
| AstraZenecaFarxiga, Symbicort | $1,205 | $44,04464 claims |
| MerckJanuvia, Janumet Xr | $49 | $41,52238 claims |
| Astellas Pharma US IncMyrbetriq | $16 | $34,05949 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,007 family providers in Mississippi.
Other family in Picayune
- Cinda PerrymanFayette$888K
- Dodie McGeeRaymond$772K
- Gina BurgeJackson$237K
- Christy DavisJackson$208K
- Maranda EversollFlowood$197K
- Dana DelaskiJackson$158K
- Kristin CarrollJackson$158K
- Shannon FryeryOxford$127K
- Nativel CollinsMantachie$73K
- Ashley CocilovaFlowood$72K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.